Literature DB >> 26354966

Optimal Usage of Colistin: Are We Any Closer?

Jason M Pogue1, Jessica K Ortwine2, Keith S Kaye3.   

Abstract

Keywords:  ascorbic acid; colistin; nephrotoxicity; pharmacokinetics/pharmacodynamics; polymyxin

Mesh：

Substances：

Year:  2015        PMID： 26354966     DOI： 10.1093/cid/civ723

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Infectious diseases: the 10 common truths I never believed.

Authors:  Jordi Rello; Emine Alp; Kalwaje Eshwara Vandana
Journal:  Intensive Care Med       Date:  2018-06-22       Impact factor: 17.440

2.  Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms.

Authors:  Elizabeth Temkin; Julian Torre-Cisneros; Bojana Beovic; Natividad Benito; Maddalena Giannella; Raúl Gilarranz; Cameron Jeremiah; Belén Loeches; Isabel Machuca; María José Jiménez-Martín; José Antonio Martínez; Marta Mora-Rillo; Enrique Navas; Michael Osthoff; Juan Carlos Pozo; Juan Carlos Ramos Ramos; Marina Rodriguez; Miguel Sánchez-García; Pierluigi Viale; Michel Wolff; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 3.  White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs.

Authors:  Helen W Boucher; Paul G Ambrose; H F Chambers; Richard H Ebright; Amanda Jezek; Barbara E Murray; Jason G Newland; Belinda Ostrowsky; John H Rex
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 7.759

4.  International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

Authors:  Brian T Tsuji; Jason M Pogue; Alexandre P Zavascki; Mical Paul; George L Daikos; Alan Forrest; Daniele R Giacobbe; Claudio Viscoli; Helen Giamarellou; Ilias Karaiskos; Donald Kaye; Johan W Mouton; Vincent H Tam; Visanu Thamlikitkul; Richard G Wunderink; Jian Li; Roger L Nation; Keith S Kaye
Journal:  Pharmacotherapy       Date:  2019-01       Impact factor: 6.251

5.  Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance.

Authors:  Aleksandra Aitullina; Angelika Krūmiņa; Šimons Svirskis; Santa Purviņa
Journal:  Medicina (Kaunas)       Date:  2019-01-31       Impact factor: 2.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.